« Return to News | Awards & Advancement

SIRO Clinpharm receives Indian CRO of the year award

Friday, September 30, 2011 11:37 AM

SIRO Clinpharm has been conferred with the Indian clinical research organization of the year 2011 award by Frost & Sullivan. The award was presented in Mumbai by Dr. Ajaykumar Sharma, pharmaceutical practice head, Frost & Sullivan, Middle East & India.

The award citation refers to SIRO Clinpharm’s leadership and accomplishments exemplified in the Indian CRO space. SIRO Clinpharm was honored for its increased visibility and reach in expanding its services overseas, which has helped the company to attain new customers and gain higher customer satisfaction. SIRO has shown consistent growth by reaching out to varied geographies from India, Malaysia and European countries and soon the company also plans to start operations in Philippines.

Dr. Ajit Nair, President, global operations, SIRO Clinpharm, said, “This award has indeed recognized our efforts in the clinical research sector. As a company we have always strived for excellence in providing clinical research services to our clients. It is a pleasure to receive this prestigious award again after 2007 and I am sure SIRO’s performance in the healthcare sector will bring in more such appreciations for the organization.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.